This is the default blog subtitle.
In order to fulfil the required regulatory obligations under the BPR in respect to the Biocidal Products that are currently in the EU market containing the Active Substance, Chrysanthemum cinerariaefolium, CAS nº: 89997-63-7, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents and obtained with supercritical CO2 Manufacturers and Distributors have […]
Read More
Are they correctly labelled? Is there any human risk derived from their use? How can their efficacy be measured? Treated Articles that incorporate a biocidal product with the intention to add new properties or functions to this article, not related to its primary use, are Biocidal Products themselves, for example: Antibacterial clothing Keyboard treated to […]
Read More
The EU Commission has recently published the Implementing Regulations that approve the biocidal active substance “Active chlorine release from hypochlorous acid” with CAS number 7790-92-3, where the following dates have been stated for the submission of the BPR Dossiers: → PT1 (Regulation 2021/365): 1st July 2021 → PT2, 3 and 4 (Regulation 2021/347): 1st July […]
Read More
Painting Products used to modify the surfaces that are treated in the sense to protect them from the development of undesired microorganisms, come under the Biocidal Product Regulation (BPR). Depending on the active substances present in the Biocidal Products, whether they are still under EU revision or they are approved, different procedures need to be […]
Read More
Sanitising products, such as hand sanitisers, come under the Biocidal Product Regulation (BPR). The most common active substance used in hand sanitisers is Ethanol. Ethanol is currently being reviewed as a biocide active substance in the EU by Greece and no tentative date for approval is known now, so Biocidal products containing Ethanol fall under […]
Read More
Please see below the latest measures taken by the EU Commission related to regulatory issues during Covid-19 Pandemic: The Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the COVID-19 pandemic. The Commission welcomes the adoption by the European Parliament and the Council of the proposal to […]
Read More
The review of biocidal active substances should be completed by the end of 2024. With only four years to go, two thirds of the work is still ahead. In February 2020, ECHA, national authorities and the European Commission agreed on an action plan to speed up the process. In 2018, ECHA carried out a survey […]
Read MoreDue to the necessity for additional disinfectant products of PT1 (human hygiene) & PT2 (surface disinfection) uses in the EU countries, some Member States are applying derogation from their current registration requirements (national or EU) so they can help companies to put new disinfectant products in the EU market quickly for the purpose of managing […]
Read More
If you are interested in supporting your Biocidal Products in the Consortia KBC System developed by KÆLTIA based on the following active substances, please be aware of their relevant submission deadlines for the BPR dossiers: EU Submission deadlines Biocide Active Substances 01 February 2020 Acetamiprid (Product Type 18) Cyphenothrin (Product Type 18) 01 June 2020 […]
Read MoreIf you are interested in supporting your Biocidal Products in the Consortia KBC System developed by KÆLTIA based on the following active substances, please be aware of their relevant submission deadlines for the BPR dossiers: EU Submission deadlines Biocide Active Substances 01 July 2019 Imiprothrin (Product Type 18) Cholecalciferol (vitamin D3) (Product Type 14) 01 […]
Read More